[{"NetIncomeLoss_1_Q1_USD":-50139000.0,"DeferredRevenueRevenueRecognized1_1_Q1_USD":108000.0,"DepreciationAndAmortization_1_Q1_USD":1929000.0,"GeneralAndAdministrativeExpense_1_Q1_USD":17838000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":41819000.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_0_Q1_USD":282894000.0,"ContractWithCustomerAssetNetCurrent_0_Q1_USD":649000.0,"BilledContractReceivables_0_Q1_USD":30584000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":-1368000.0,"RestrictedCashAndCashEquivalentsNoncurrent_0_Q1_USD":1330000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_0_Q1_USD":93800000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":-214183000.0,"StockIssuedDuringPeriodValueNewIssues_1_Q1_USD":216059000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q1_USD":755000.0,"AssetsCurrent_0_Q1_USD":498638000.0,"OtherNoncashIncomeExpense_1_Q1_USD":154000.0,"AccountsReceivableNetNoncurrent_0_Q1_USD":2859000.0,"ContractWithCustomerLiability_0_Q1_USD":4124000.0,"CostOfGoodsAndServicesSold_1_Q1_USD":4851000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":7630000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q1_USD":1292000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_1_Q1_USD":-1008000.0,"ProvisionForOtherCreditLosses_1_Q1_USD":565000.0,"CommonStockSharesIssued_0_Q1_shares":42505000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q1_USD":364996000.0,"Assets_0_Q1_USD":879442000.0,"MarketableSecuritiesCurrent_0_Q1_USD":149398000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q1_USD":-1008000.0,"PreferredStockSharesOutstanding_0_Q1_shares":0.0,"Liabilities_0_Q1_USD":324938000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":39722000.0,"DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_0_Q1_USD":755000.0,"IncreaseDecreaseInPrepaidExpense_1_Q1_USD":3334000.0,"PrepaidExpenseCurrent_0_Q1_USD":13839000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax_1_Q1_USD":-1008000.0,"AccountsReceivableNetCurrent_0_Q1_USD":41039000.0,"IncomeTaxExpenseBenefit_1_Q1_USD":4000.0,"CommonStockValue_0_Q1_USD":4000.0,"DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_0_Q1_Security":49.0,"InvestmentIncomeNet_1_Q1_USD":580000.0,"IncreaseDecreaseInOtherCurrentAssets_1_Q1_USD":873000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":208370000.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_0_Q1_USD":755000.0,"CostsAndExpenses_1_Q1_USD":62926000.0,"PaymentsOfStockIssuanceCosts_1_Q1_USD":251000.0,"ProceedsFromSaleAndMaturityOfMarketableSecurities_1_Q1_USD":50465000.0,"CashCashEquivalentsAndShortTermInvestments_0_Q1_USD":656500000.0,"AccountsAndNotesReceivableNet_0_Q1_USD":43898000.0,"OtherAssetsCurrent_0_Q1_USD":2880000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax_1_Q1_USD":-1001000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":-51147000.0,"OtherAssetsNoncurrent_0_Q1_USD":9068000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":291482000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":75078000.0,"AdditionalPaidInCapitalCommonStock_0_Q1_USD":895079000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q1_USD":-1008000.0,"IncreaseDecreaseInOtherNoncurrentAssets_1_Q1_USD":3789000.0,"ShareBasedCompensation_1_Q1_USD":9920000.0,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.0001,"IncreaseDecreaseInAccountsReceivable_1_Q1_USD":-1618000.0,"CommonStockSharesOutstanding_0_Q1_shares":42505000.0,"PaymentsToAcquireMarketableSecurities_1_Q1_USD":233627000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q1_USD":24602000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q1_USD":247000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q1_USD":-50135000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":9920000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-41131000.0,"MarketableSecuritiesNoncurrent_0_Q1_USD":215598000.0,"LiabilitiesCurrent_0_Q1_USD":83961000.0,"AccountsPayableCurrent_0_Q1_USD":11311000.0,"NonoperatingIncomeExpense_1_Q1_USD":-6093000.0,"InterestExpense_1_Q1_USD":6702000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":292812000.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_1_Q1_USD":627000.0,"ProceedsFromStockOptionsExercised_1_Q1_USD":1292000.0,"OtherAccruedLiabilitiesCurrent_0_Q1_USD":122000.0,"AccruedIncomeTaxesCurrent_0_Q1_USD":4005000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q1_USD":292812000.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_1_Q1_USD":627000.0,"DebtSecuritiesAvailableForSaleUnrealizedLossPosition_0_Q1_USD":282894000.0,"PreferredStockSharesIssued_0_Q1_shares":0.0,"CapitalExpendituresIncurredButNotYetPaid_1_Q1_USD":3783000.0,"ReceivablesNetCurrent_0_Q1_USD":41039000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":89342000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":-46944000.0,"OperatingLeaseRightOfUseAsset_0_Q1_USD":62607000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-339211000.0,"IncreaseDecreaseInOtherOperatingLiabilities_1_Q1_USD":-38000.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.0001,"AccountsReceivableNet_0_Q1_USD":43898000.0,"IncreaseDecreaseInAccountsPayableTrade_1_Q1_USD":278000.0,"CommonStockSharesAuthorized_0_Q1_shares":100000000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q1_USD":18884000.0,"OperatingIncomeLoss_1_Q1_USD":-44042000.0,"OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale_1_Q1_USD":0.0,"ContractWithCustomerLiabilityCurrent_0_Q1_USD":395000.0,"PreferredStockValue_0_Q1_USD":null,"LiabilitiesAndStockholdersEquity_0_Q1_USD":879442000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q1_USD":7970000.0,"PreferredStockSharesAuthorized_0_Q1_shares":10000000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":9920000.0,"PropertyPlantAndEquipmentGross_0_Q1_USD":113944000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":1843000.0,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_1_Q1_USD":-10544000.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-1.2,"ProfitLoss_1_Q1_USD":-50139000.0,"OtherLiabilitiesNoncurrent_0_Q1_USD":448000.0,"StockholdersEquity_0_Q1_USD":554504000.0,"DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_0_Q1_USD":0.0,"ContractWithCustomerLiabilityNoncurrent_0_Q1_USD":3729000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":31021000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q1_USD":365504000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_1_Q1_USD":-1288000.0,"RevenueFromContractWithCustomerIncludingAssessedTax_1_Q1_USD":18263000.0,"UnbilledReceivablesCurrent_0_Q1_USD":18698000.0,"Ticker":"RGNX","CIK":"1590877","name":"REGENXBIO INC.","OfficialName":"REGENXBIO Inc. Common Stock","form":"10-Q","period":"20210331","fy":"2021.0","fp":"Q1","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"1299022052.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20210505"}]